We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Morgan Goodwin is a UK-based company that pioneers the Combined Trading Platform (CTP) category, offering a comprehensive online platform for small businesses engaged in physical goods trading, along with specialized software development services, and a broad-spectrum business consultancy approach aimed at enhancing growth, efficiency, and technological advancement.
days to go: Stretch investment: £788,519
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Doqit offers a solution for managing life admin tasks, helping you organize important information, set action dates, and receive timely reminders, ultimately streamlining tasks like insurance renewals and warranties to reduce unnecessary expenses and simplify your life. It provides secure storage and easy access for vital information, transitioning from chaos to simplicity.  Security is also a priority for Doqit. The platform ensures that your sensitive information is stored securely, giving you peace of mind knowing that you can access your important documents and data whenever you need them, all within a few clicks.
days to go: Extended investment: £87,500
UTU is a company dedicated to building the trust infrastructure for the evolving web 3.0. They aim to facilitate safer and more reliable interactions between users and platforms by utilizing a decentralized reputation and reviews protocol. This protocol involves a non-tradable reputation token (UTT) that users can stake to endorse others, leading to positive outcomes. UTU's focus initially lies in Web3 and DeFi apps, where they provide AI-powered tools to curate trust signals and help users engage confidently in various online activities. They offer a range of products, including the UTU Trust Token, Browser Extension, and Trust API/SDK, all aimed at enhancing trust and security in digital interactions.
days to go: Extended investment: £150,000
Enabling mobile network operators to improve their energy efficiencies whilst reducing their costs and environmental pollution. PowerX has created an AI platform with the aim of helping mobile networks reduce the level of emissions produced from their operations. The platform, dubbed Thalesto™, has been developed on IBM Cloud™ and utilises their IBM Watson™ technology. As a result, IBM® is now the sales channel for the platform and PowerX is currently in discussion with Ericsson as a potential future partner. The company has predicted their solution will cost operators £23 per mobile tower, but will result in £115 saved per tower.
days to go: Expired investment: £755,001
Bodytrak is a wearable technology that monitors physiological activity such as heart rate and core body temperature.  This real time data is analysed using cloud based technology and algorithms to supervisors or commanders so early action can be taken on the event of illness or injury.
days to go: Expired investment: £1,123,119
Beacon is a company that offers software and supporting services to help a client optimise their digital marketing efforts and improve their marketing Return-on-Investment (ROI). The company offers clients services like campaign management, PPC (Pay Per Click) campaign analytics, social media analytics, and anti-fraudulent click system etc. Using the company's portal, marketers can compare costs and revenue across all digital channels, channel by channel, and with their off-line marketing efforts. Beacon aims at removing ‘non-human clicks’ and giving direct independent attribution of emails, posts, ad’s, etc. to specific website actions and business goals thereby improving engagement and reducing costs. According to Stratistics Market Research Consulting, the web analytics tools market is expected to reach $4.9 billion by 2022, growing at a Compound Annual Growth Rate (CAGR) of 20.8%, in which, Beacon aims to be a leading contender. The company will use the investment to grow its business across different verticals.

Pitch Rated

75%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £240,000
SkiBro is a leading business-to-customer (B2B) Software as a Service (SaaS) platform that aspires to become a contender in the €2 billion ski lessons market. The platform has onboarded 8,000 ski schools and 150,000 ski instructors to date. SkiBro's marketplace encompasses 350 resorts in 7 countries across Europe and North America, with over 6,000 ski instruction products. SkiBro intends to expand into ski hire. The platform has 350 independent ski instructors (250 last year) and 400+ ski schools, with notable ones including ESF La Plagne, ESF Courchevel, Evolution2 (France), Skischule Alberg (Austria), and Ski and Snowboard School Courmayeur (Italy). The company claims that despite COVID-19 hampering business in March 2020, the platform hosted 8.467 lesson bookings worth €1.35 million, recording a 500% YoY growth with an average booking value of €453. SkiBro is seeking £1.5 million of equity funding to accelerate company growth and deliver profitability in 2023-2024.
days to go: Expired investment: £749,825
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph